Answer Regarding: Potent P2Y12 Inhibitors and Bleeding Complications

Akıncı, Sinan; Çoner, Ali; Akbay, Ertan; Adar, Adem; Muderrisoğlu, Ibrahim Haldun

Journal Metrics

Impact Factor (2022): 0.8
CiteScore (2022): 1.2
Source Normalized Impact
per Paper: 0.22
SCImago Journal Rank: 0.348

52/3Current Issue Ahead of Print Archive Most Accessed Articles

Quick Search

In authors and

In titles and abstracts

In keywords

In all

Archives of the Turkish Society of Cardiology

Answer Regarding: Potent P2Y12 Inhibitors and Bleeding Complications [Turk Kardiyol Dern Ars]

Turk Kardiyol Dern Ars. 2022; 50(7): 545-546 | DOI: 10.5543/tkda.2022.220922

Answer Regarding: Potent P2Y12 Inhibitors and Bleeding Complications

Sinan Akıncı¹, Ali Çoner¹, Ertan Akbay¹, Adem Adar¹, Ibrahim Haldun Muderrisoğlu²
¹Department of Cardiology, Başkent University Faculty of Medicine Alanya Application and Research Center, Antalya, Turkey
²Department of Cardiology, Başkent University Faculty of Medicine, Ankara, Turkey

How to cite this article
Sinan Akıncı, Ali Çoner, Ertan Akbay, Adem Adar, Ibrahim Haldun Muderrisoğlu. Answer Regarding: Potent P2Y12 Inhibitors and Bleeding Complications. Turk Kardiyol Dern Ars. 2022; 50(7): 545-546

Corresponding Author: Sinan Akıncı
Manuscript Language: English

TOOLS English Full Text Print Download citation RIS EndNote BibTex Medlars Procite Reference Manager Share with email Share Similar articles PubMed Google Scholar